Baillie Gifford - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 118 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 3.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$39,490,931
-38.9%
10,204,375
-5.8%
0.04%
-34.5%
Q2 2023$64,583,520
+81.6%
10,836,161
-0.4%
0.06%
+71.9%
Q1 2023$35,567,558
-16.4%
10,876,929
+1.0%
0.03%
-27.3%
Q4 2022$42,520,672
-35.4%
10,764,727
-1.8%
0.04%
-35.3%
Q3 2022$65,800,000
-7.1%
10,966,736
-0.4%
0.07%
-6.8%
Q2 2022$70,804,000
-22.7%
11,011,462
-0.7%
0.07%
+14.1%
Q1 2022$91,569,000
-47.5%
11,085,861
-1.6%
0.06%
-33.3%
Q4 2021$174,337,000
-30.8%
11,262,030
+0.6%
0.10%
-27.3%
Q3 2021$251,995,000
+14.0%
11,189,832
-0.5%
0.13%
+22.2%
Q2 2021$221,014,000
-33.9%
11,241,851
+12.6%
0.11%
-42.2%
Q1 2021$334,284,0009,987,5450.19%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 25,001,856$96,757,1837.02%
Omega Fund Management, LLC 843,750$3,265,3133.00%
Crestline Management, LP 3,365,624$13,024,9651.52%
Trustees of Columbia University in the City of New York 98,353$380,6260.70%
Alphabet Inc. 2,812,500$10,884,3750.70%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,963,704$11,469,5340.62%
Casdin Capital, LLC 750,000$2,902,5000.32%
PFM Health Sciences, LP 1,244,139$4,814,8180.23%
HARBOURVEST PARTNERS LLC 137,694$532,8760.18%
GSA CAPITAL PARTNERS LLP 540,250$2,0910.18%
View complete list of SANA BIOTECHNOLOGY INC shareholders